1 Min Read
Jan 31 (Reuters) - A1M PHARMA AB:
* A1M PHARMA SUBMITS APPLICATION TO THE SWEDISH MEDICAL PRODUCTS AGENCY TO CONDUCT CLINICAL PHASE I STUDY WITH ROSGARD™ Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.